Stephens Inc’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Stephens Inc’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,935	Closed	-$222K	–	1257
2022 Q4	$222K	Sell	1,935 -100	-5%	-$11K	﹤0.01%	970
2022 Q3	$206K	Hold	2,035	–	–	﹤0.01%	1024
2022 Q2	$206K	Hold	2,035	–	–	﹤0.01%	1061
2022 Q1	$237K	Hold	2,035	–	–	﹤0.01%	1107
2021 Q4	$233K	Buy	+2,035	New	+$232K	﹤0.01%	1147

Other funds holding BSX.PRA

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Stephens Inc's BSX.PRA Position: Q1 2023 in Review

Stephens Inc sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q1 2023, closing a stake of 1,935 shares — an estimated $222K sold.

Stephens Inc first reported a position in BSX.PRA in Q4 2021 and held it in 5 quarters. The position peaked at $237K in Q1 2022. 56 funds tracked by Wall St. Rank hold BSX.PRA as of Q1 2023.

Stephens Inc reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q1 2023 after selling out during the quarter.
Stephens Inc sold 1,935 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q1 2023, an estimated $222K.
Stephens Inc first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 5 quarters.
Stephens Inc's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $237K in Q1 2022.
56 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q1 2023.

Based on Stephens Inc's 13F filing for Q1 2023, filed 15 May 2023.